Abstract
AbstractStudies on cancer resistance in the naked mole-rat (NMR) have generally failed to interrogate possible resistance mechanisms in a physiological context. Here, we provide evidence that the NMR presents as a novel model of tumor initiation. We developed an endogenous lung cancer model in NMRs, driven by an oncogenic Eml4-Alk fusion protein introduced through CRISPR- mediated genome editing. While this is sufficient to drive tumorigenesis in mice, the development of progressive disease in NMRs required the additional loss of key tumor suppressors. Our results show that tumor initiation in NMRs more closely recapitulates that of human tumors. This suggests that the proposed “resistance” of NMRs to cancer development may stem from tumor initiation events that are likely to be comparable to the mechanisms in human cells.One-Sentence SummaryTumor development in the cancer-resistant naked mole-rat more accurately represents the tumor initiation process in humans.
Publisher
Cold Spring Harbor Laboratory